<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-03-07">07 March 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Agnes</forename><surname>Flöel</surname></persName>
							<email>agnes.floeel@uni-greifswald.de</email>
							<affiliation key="aff2">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">NeuroCure Cluster of Excellence</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Center for Stroke Research Berlin</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">University Medicine Greifswald</orgName>
								<address>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Theresa</forename><surname>Köbe</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">NeuroCure Cluster of Excellence</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">Veronica</forename><surname>Witte</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">NeuroCure Cluster of Excellence</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Max Planck Institute of Human Cognitive and Brain Sciences</orgName>
								<address>
									<settlement>Leipzig, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="laboratory">SFB 1052 Obesity Mechanism Subproject A1</orgName>
								<orgName type="institution">University of Leipzig</orgName>
								<address>
									<settlement>Leipzig, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ariane</forename><surname>Schnelle</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">NeuroCure Cluster of Excellence</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Valentina</forename><forename type="middle">A</forename><surname>Tesky</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of General Medicine</orgName>
								<orgName type="institution">Goethe-University</orgName>
								<address>
									<settlement>Frankfurt am Main, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johannes</forename><surname>Pantel</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of General Medicine</orgName>
								<orgName type="institution">Goethe-University</orgName>
								<address>
									<settlement>Frankfurt am Main, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan-Philipp</forename><surname>Schuchardt</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Nutrition Physiology and Human Nutrition</orgName>
								<orgName type="institution">Gottfried Wilhelm Leibniz University</orgName>
								<address>
									<settlement>Hannover, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Hahn</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Nutrition Physiology and Human Nutrition</orgName>
								<orgName type="institution">Gottfried Wilhelm Leibniz University</orgName>
								<address>
									<settlement>Hannover, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jens</forename><surname>Bohlken</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Medical Practice Bohlken for Neurology and Psychiatry</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulrike</forename><surname>Grittner</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Biostatistics and Clinical Epidemiology</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">Institut National de la Santé et de la Recherche Médicale</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">University of Illinois at Urbana-Champaign</orgName>
								<address>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-03-07">07 March 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">53CA113FD9AA3D4C204D06C6E69E9E58</idno>
					<idno type="DOI">10.3389/fnins.2017.00105</idno>
					<note type="submission">This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience Received: 21 October 2016 Accepted: 20 February 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:48+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>hippocampus</term>
					<term>memory performance</term>
					<term>MCI</term>
					<term>resting-state functional connectivity</term>
					<term>resveratrol Magnetic Resonance Image (MRI) Acquisition</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>In healthy older adults, resveratrol supplementation has been shown to improve long-term glucose control, resting-state functional connectivity (RSFC) of the hippocampus, and memory function.</s><s>Here, we aimed to investigate if these beneficial effects extend to individuals at high-risk for dementia, i.e., patients with mild cognitive impairment (MCI).</s><s>In a randomized, double-blind interventional study, 40 well-characterized patients with MCI (21 females; 50-80 years) completed 26 weeks of resveratrol (200 mg/d; n = 18) or placebo (1,015 mg/d olive oil; n = 22) intake.</s><s>Serum levels of glucose, glycated hemoglobin A1c and insulin were determined before and after intervention.</s><s>Moreover, cerebral magnetic resonance imaging (MRI) (3T) (n = 14 vs. 16) was conducted to analyze hippocampus volume, microstructure and RSFC, and neuropsychological testing was conducted to assess learning and memory (primary endpoint) at both time points.</s><s>In comparison to the control group, resveratrol supplementation resulted in lower glycated hemoglobin A1c concentration with a moderate effect size (ANOVA RM p = 0.059, Cohen's d = 0.66), higher RSFC between right anterior hippocampus and right angular cortex (p &lt; 0.001), and led to a moderate preservation of left anterior hippocampus volume (ANOVA RM p = 0.061, Cohen's d = 0.68).</s><s>No significant differences in memory performance emerged between groups.</s><s>This proof-of-concept study indicates for the first-time that resveratrol intake may reduce glycated hemoglobin A1c, preserves hippocampus volume, and improves hippocampus RSFC in at-risk patients for dementia.</s><s>Larger trials with longer intervention time should now determine if these benefits can be validated and extended to cognitive function.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>The growing incidence of Alzheimer's disease worldwide and the lack of curative pharmacological approaches increase the demand for alternative preventive strategies at earlier disease stages, i.e., in patients with mild cognitive impairment (MCI).</s><s>Nutrition is now well-recognized as a factor that influences brain structure, functional connectivity, and cognition and may modulate the rate and degree of disease progression <ref type="bibr" target="#b17">(Gustafson et al., 2015;</ref><ref type="bibr" target="#b20">Huhn et al., 2015)</ref>.</s></p><p><s>Caloric restriction and administration of caloric restriction mimetics like the polyphenol resveratrol might provide a promising avenue to slow brain atrophy and cognitive decline <ref type="bibr" target="#b24">(Kim et al., 2007;</ref><ref type="bibr" target="#b8">Dal-Pan et al., 2011;</ref><ref type="bibr" target="#b52">Willette et al., 2012)</ref>.</s><s>It has been shown that physiological doses of resveratrol are safe and well-tolerated and that the substance is able to penetrate the blood-brain barrier to influence the central nervous system <ref type="bibr" target="#b48">(Turner et al., 2015)</ref>.</s></p><p><s>Several studies in mice demonstrated resveratrol-mediated neuroprotective effects on key features of Alzheimer's disease, including decreased amyloid deposition, reduced tau hyperphosphorylation <ref type="bibr" target="#b39">(Porquet et al., 2013)</ref>, enhanced neurogenesis in the hippocampus (HC) <ref type="bibr" target="#b18">(Harada et al., 2011)</ref>, and improved memory function linked to activation of longevity genes, i.e., Silent Information Regulator T1 <ref type="bibr" target="#b57">(Zhao et al., 2013)</ref>.</s><s>In primates, spatial memory performance was improved after resveratrol intake <ref type="bibr" target="#b8">(Dal-Pan et al., 2011)</ref>.</s></p><p><s>Moreover, first resveratrol interventional trials were conducted in humans, showing positive influence on cerebral blood flow <ref type="bibr" target="#b22">(Kennedy et al., 2010)</ref>, glucose control <ref type="bibr" target="#b3">(Brasnyo et al., 2011;</ref><ref type="bibr" target="#b1">Bhatt et al., 2012;</ref><ref type="bibr" target="#b7">Crandall et al., 2012)</ref>, and verbal episodic memory performance <ref type="bibr" target="#b54">(Witte et al., 2014)</ref>.</s><s>No beneficial effects on brain volume have been found in human trials so far <ref type="bibr" target="#b54">(Witte et al., 2014;</ref><ref type="bibr" target="#b48">Turner et al., 2015)</ref>.</s><s>In sum, beneficial effects in healthy adults are not yet conclusive <ref type="bibr" target="#b56">(Wong et al., 2013;</ref><ref type="bibr" target="#b54">Witte et al., 2014;</ref><ref type="bibr" target="#b51">Wightman et al., 2015)</ref>, possibly due to short intervention times of 4-6 weeks in trials with a negative outcome <ref type="bibr" target="#b56">(Wong et al., 2013;</ref><ref type="bibr" target="#b51">Wightman et al., 2015)</ref>.</s><s>Moreover, studies that investigate the impact of resveratrol on cognition and brain networks in individuals at high-risk for dementia, like MCI patients, are missing so far.</s></p><p><s>The previous positive trial on resveratrol supplementation in healthy older adults evaluated a 26-week intervention with 200 mg resveratrol, showing an improvement in verbal episodic memory performance.</s><s>Potential mechanisms underlying this effect were also described, such as a significant decrease in glycated hemoglobin A1c (HbA1c) and an increase in restingstate functional connectivity (RSFC) between the HC and frontal, parietal, and occipital brain regions <ref type="bibr" target="#b54">(Witte et al., 2014)</ref>.</s></p><p><s>Based on these findings, we now aimed to improve verbal episodic memory function in memory-impaired patients at highrisk for dementia (primary endpoint).</s><s>Therefore, we conducted a similarly designed proof-of-concept study (double-blind, randomized-controlled) with MCI patients, assessing the effects of a 26-week resveratrol supplementation.</s><s>Moreover, we aimed to investigate glucose metabolism, total gray matter volume, and RSFC and structure of the HC, a key region implicated in memory function <ref type="bibr" target="#b55">(Wittenberg and Tsien, 2002)</ref> and known to be affected early in the course of Alzheimer's disease <ref type="bibr" target="#b42">(Ries et al., 2008)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p><s>The study was approved by the Ethics Committee of the Charité University Hospital Berlin, Germany, and was in accordance with the declaration of Helsinki.</s><s>All subjects provided informed written consent before participation in the study and received a small reimbursement at the end.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Participants</head><p><s>Patients (aged 50-80 years) with MCI were recruited in Berlin (Memory Clinic of the Department of Neurology of the Charité University Hospital and Neurology specialist practice) and Frankfurt am Main (Institute of General Practice), Germany.</s><s>MCI patients (amnestic; single and multiple domain) were diagnosed according to Mayo criteria within 12 months before baseline visit.</s><s>These criteria comprised a subjective cognitive complaint and an objective memory impairment in standardized tests [performing at least one standard deviation below age-and education-specific norm in relevant subtests of the CERAD-Plus or Rey Auditory Verbal Learning Test (AVLT) battery (Total Word List, Delayed Recall Word List/Figures) <ref type="bibr" target="#b34">(Morris et al., 1989)</ref>].</s><s>Moreover, patients showed relatively preserved general cognition, no impairment in activities of daily living, and no dementia <ref type="bibr" target="#b37">(Petersen et al., 1999)</ref>.</s><s>Exclusion criteria comprised MMSE scores &lt;24 at baseline visit, severe untreated medical, neurological or psychiatric diseases and brain pathologies identified in the magnetic resonance imaging (MRI) scan, no right-handedness <ref type="bibr" target="#b36">(Oldfield, 1971)</ref>, non-fluent German language and BMI &lt;18 kg/m 2 or &gt;35 kg/m 2 .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Design</head><p><s>One-hundred-ten patients, previously diagnosed with MCI, were screened for study eligibility by telephone (e.g., for additional severe diseases, known brain pathologies, MR ineligibility).</s><s>Twenty-two had to be excluded on the basis of these criteria.</s><s>The remaining 88 patients were invited for baseline assessment.</s><s>From this group, 11 patients had to be excluded either due to a pathological MRI finding (n = 3) or due to comorbidities (n = 8; Parkinson's disease, depression).</s><s>Eligible patients were allocated in different intervention groups (details below) by a simple randomization approach, based on a computer-generated list of random numbers, carried out by an investigator that was not involved in the study.</s><s>Thirty-five patients were randomized into a separate study testing the effect of omega-3 fatty acids on brain structure and function.</s><s>Two patients (resveratrol n = 1; placebo n = 1) did not complete the intervention due to time constraints.</s><s>In total, 40 MCI patients completed the current study (resveratrol n = 18; placebo n = 22; see Figure <ref type="figure">1</ref>).</s><s>MRI scans from follow-up were not available for 10 patients (scheduling problems at follow-up), leaving 30 patients for longitudinal MRI analysis (resveratrol n = 14; placebo n = 16).</s></p><p><s>During baseline assessment, patients underwent a standardized medical examination, neuropsychological testing, FIGURE 1 | Study flow chart.</s><s>In total, 110 MCI patients were screened on telephone, of which 88 were invited for baseline assessment.</s><s>Forty-two patients met the inclusion criteria and were randomized to the resveratrol intervention group (n = 19) or to the placebo intervention group (n = 23).</s><s>Two patients did not complete participation due to time constraints.</s><s>Thus, 40 patients successfully completed the intervention over 26 weeks (resveratrol n = 18; placebo n = 22).</s><s>Before and after the intervention period, patients underwent a standardized medical examination, including neuropsychological testing, cerebral magnetic resonance imaging (MRI), anthropometry, and fasting blood draw for detection of serum parameters and APOE e4 status.</s><s>MRI scans from both time points baseline and follow-up were not available for 10 patients (scheduling problems at follow-up), leaving 30 patients for longitudinal MRI analysis (resveratrol n = 14; placebo n = 16).</s></p><p><s>structural and resting-state functional MRI of the brain, as well as fasting blood sampling, and assessments of anthropometric data and mood (baseline assessment; see Figure <ref type="figure">1 and Table 1</ref>).</s></p><p><s>MCI patients were randomized in either a resveratrol or placebo group, receiving a daily supplementation of 200 mg resveratrol, plus 350 mg quercetin to increase bioavailability of resveratrol <ref type="bibr" target="#b12">(De Santi et al., 2000)</ref>, or 1,015 mg olive oil, respectively.</s><s>Patients were instructed to follow a regular intake once a day (4 capsules) before or at a main meal for 26 weeks.</s><s>Resveratrol intake was well tolerated with no reported treatmentrelated serious adverse events that would have led to study termination.</s><s>Each patient received half of their study medication at baseline and the second half after 13 weeks.</s></p><p><s>Capsules were provided by VIA Vitamine, Oberhausen, Germany.</s><s>Following the intervention, baseline measurements were repeated (follow-up assessment; see Figure <ref type="figure">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Compliance of Capsule Intake</head><p><s>The number of remaining resveratrol or placebo capsules was counted after 13 and 26 weeks, showing a &gt;83% compliance rate.</s><s>Moreover, patients completed a questionnaire on capsule intake at the end of the study.</s><s>Misses of capsule intake exceeding 5 times/ month would have led to pre-specified exclusion from analysis.</s><s>However, none of the patients had to be excluded in this study due to capsule misses.</s><s>Patients were instructed not to change their dietary habits and their physical activity throughout the intervention.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neuropsychological Assessment</head><p><s>Learning and episodic declarative memory performance of MCI patients was tested, using the German version of the Rey Auditory Verbal Learning Test (AVLT) <ref type="bibr" target="#b30">(Lezak, 2004)</ref>.</s><s>Patients were asked to learn a list of 15 words within five immediate recall trials, followed by a 30 min delayed recall and delayed recognition test.</s><s>Learning ability was defined as the sum of words learned in all five trials (maximum 75 words).</s><s>Delayed recall represented the total number of remembered words after 30 min (maximum 15 words).</s><s>For delayed recognition, MCI patients were asked to recognize the 15 original words presented within 35 distractor words subsequent to the delayed recall test (number of correctly recognized words minus false positive words; maximum 15 words).</s><s>Trained staff members conducted all tests according to standardized procedures.</s><s>Data expressed as mean ± SD (range; min-max).</s><s>a Twelve or b four patients were excluded due to missing values, respectively.</s><s>c One extreme outlier (27.7 pg/ml) within the resveratrol group was excluded (indicating an acute infection).</s><s>Adjusting for differences in CRP value did not attenuate the beneficial effect of resveratrol on HbA1c concentration, HC RSFC, and HC volume compared with placebo.</s></p><p><s>High resolution T1-weighted scans (3D Magnetization Prepared Rapid Acquisition with Gradient Echoes (MPRAGE); TR = 1,900 ms, TE = 2.52 ms, 192 sagittal slices, voxel-size of 1.0 × 1.0 × 1.0 mm 3 , flip angle = 9 • ), and diffusion-weighted spin-echo echo-planar imaging (EPI) scans (TR = 7,500 ms, TE = 86 ms, 61 axial slices, voxel size of 2.3 × 2.3 × 2.3 mm 3 ; 64 directions with a b-value of 1,000 s/mm 2 and 10 b0) were acquired.</s></p><p><s>Functional scans were obtained at rest using a T2 * -weighted EPI sequence (TR = 2,300 ms, TE = 30 ms, 34 slices, voxel size of 3.0 × 3.0 × 4.0 mm 3 , flip angle = 90 • ).</s><s>Patients were instructed to keep their eyes closed, relax, think of nothing in particular and move as little as possible during this 6 min scan.</s></p><p><s>Image preprocessing and analyses were done using the software package FSL 4.1 (http://www.fmrib.ox.ac.uk/fsl),</s><s>AFNI 2011 (http://afni.nimh.nih.gov/afni), and FreeSurfer 5.3 (http:// surfer.nmr.mgh.harvard.edu/),</s><s>as indicated below.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MRI Analyses</head><p><s>MRI analyses were performed according to <ref type="bibr" target="#b54">Witte et al. (2014)</ref>, where the procedure is described in detail.</s></p><p><s>Briefly, volumetric delineation of the total gray matter, and left and right HC was conducted, using FSL and Freesurfer brain extraction tools (BET and mri_watershed), FMRIB's Automated Segmentation Tool (FAST) and Integrated Registration and Segmentation Tool (FIRST).</s><s>To determine the respective anterior and posterior parts, the center of gravity of the HC was assessed after rigid body transformation to MNI space and the corresponding y-coordinate then served as a measure for individual anterior/posterior-division.</s></p><p><s>Individual HC volumes were adjusted for intracranial volume (ICV), according to previous studies <ref type="bibr" target="#b41">(Raz et al., 2005;</ref><ref type="bibr" target="#b10">den Heijer et al., 2012;</ref><ref type="bibr" target="#b23">Kerti et al., 2013)</ref>, using the following formula: adjusted volume = raw volume − b × (ICV − mean ICV).</s><s>The coefficient b represents the slope of regression of a region of interest volume on ICV.</s><s>The results of HC segmentation were superimposed on anatomic images and visually inspected to exclude misregistration or erroneous HC identification.</s></p><p><s>Hippocampal microstructure was assessed by mean diffusivity (MD), estimated by using diffusion tensor imaging (DTI), in line with previous studies (den <ref type="bibr" target="#b10">Heijer et al., 2012;</ref><ref type="bibr" target="#b23">Kerti et al., 2013)</ref>.</s><s>Therefore, a tensor model was fitted to the motion-corrected DTI data at each voxel to create individual 3-dimensional maps of MD.</s><s>Then, individual T1-weighted images were coregistered to the b0 images, using rigid-body transformation.</s><s>These registrations were used to transform masks of the left and right anterior and posterior HC (derived from the T1 images) to the MD maps, for extraction of the mean individual hippocampal MD values.</s><s>For this analysis FSL software was used.</s></p><p><s>To assess potential changes in RSFC of the HC, we used a customized processing stream based on the 1,000 Functional Connectomes Project (http://www.nitrc.org/projects/fcon_1000)</s><s><ref type="bibr" target="#b2">(Biswal et al., 2010)</ref>.</s><s>Co-registered masks of the left and right anterior and posterior HC served as seeds for RSFC analysis, in line with previous studies <ref type="bibr" target="#b43">(Rombouts et al., 2005;</ref><ref type="bibr" target="#b0">Andrews-Hanna et al., 2010;</ref><ref type="bibr" target="#b54">Witte et al., 2014)</ref>.</s><s>Pre-processing of individual functional scans comprised slice time correction, motion correction, spatial smoothing with a 6 mm full-widthhalf-maximum (FWHM) Gaussian kernel, temporal filtering (0.01-0.1 Hz), and de-trending, using AFNI and FSL software.</s><s>The functional scans were normalized to the anatomical image, using affine co-registrations.</s><s>Noise due to motion, white matter, cerebrospinal fluid, and global change was removed from the functional signal by multiple regressions, creating standardized residual BOLD-signal time series (in FSL).</s><s>Then, mean time series of the individual HC seeds were correlated with times series of all other gray matter voxels in the brain, using a general linear model approach within FSL (FMRIB's local analysis of mixed effects with Ordinary Least Square option, FLAMEO).</s><s>The resulting Pearson's r correlation coefficient 3D maps were then Fisher's z-transformed and smoothed, using a kernel of sigma = 1 to improve normality.</s><s>This produced spatial maps in which the values of voxels represented the strength of the correlation with the individual HC seeds.</s><s>Registration of individual z-maps for group analysis included a rigid body within-subject registration of both time points to a "halfway space" before affine and nonlinear registrations to a study-specific template, as described in detail in previous studies <ref type="bibr" target="#b54">(Witte et al., 2014;</ref><ref type="bibr" target="#b25">Köbe et al., 2016)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SNP Genotyping</head><p><s>DNA was extracted from whole blood, using a blood mini-kit (Qiagen, Hilden, Germany) and stored at −80 • C until analysis.</s><s>Genotyping of the single nucleotide polymorphisms (SNP) apolipoprotein E (APOE) rs429358 and rs7412 that have been previously implicated in cognitive performance <ref type="bibr" target="#b6">(Corder et al., 1993;</ref><ref type="bibr" target="#b14">Egan et al., 2003;</ref><ref type="bibr" target="#b53">Witte and Floel, 2012)</ref> was performed, using a pre-designed Taqman assay at the laboratory of Prof. Dr. Dan Rujescu (University of Halle, Germany), following procedures described previously <ref type="bibr" target="#b35">(O'Dwyer et al., 2012)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood Markers of Glucose Control, Anthropometric Measures and Mood</head><p><s>After fasting overnight of at least 10 h, all subjects underwent venous blood sampling for assessment of serum levels of glucose, glycated hemoglobin A1c as long-term measure of glucose, insulin, high-to-low density lipoprotein (HDL-to-LDL) ratio, and high-sensitive C-reactive protein (hsCRP).</s><s>All parameters were analyzed by IMD Laboratory, Berlin, Germany.</s><s>Anthropometric measures included weight and body mass index (BMI).</s><s>Patients also reported their physical activity and other lifestyle habits, using the Freiburger physical activity questionnaire <ref type="bibr" target="#b15">(Frey et al., 1999)</ref>.</s><s>For mood ratings during neuropsychological testing, the Positive and Negative Affective Schedule (PANAS; <ref type="bibr" target="#b27">Krohne et al., 1996)</ref> was used.</s><s>Moreover, to characterize each patient's depression and anxiety level at baseline, the Beck's Depression Inventory (BDI; <ref type="bibr" target="#b28">Kuhner et al., 2007)</ref> and the State-Trait Anxiety Inventory (STAI X1; <ref type="bibr" target="#b29">Laux et al., 1981)</ref> were used.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analyses</head><p><s>Before data analysis, all variables were tested for normal or nearnormal distribution (unimodal, |skewness| &lt;1).</s><s>Accordingly, parametric and non-parametric tests were calculated, as appropriate.</s><s>Two-sided level of significance was set at α &lt; 0.05.</s><s>SPSS 23.0 (PASW, SPSS; IBM, Armonk, NY) was used for the analysis.</s></p><p><s>At baseline, parameters of memory performance, glucose metabolism, HC volume and microstructure were compared between groups, using independent t-tests or Mann-Whitney U-tests, as appropriated.</s><s>To detect differences between groups with regard to changes over time in these parameters, we performed repeated-measures analysis of variance (ANOVA RM ) with "time" as repeated factor (baseline, follow-up) and "group" as between-subject factor (resveratrol, placebo intervention).</s><s>Changes over intervention time within groups were evaluated, using paired t-tests or Wilcoxon signed-rank tests, as appropriate.</s><s>Correction for multiple comparison was applied for our primary hypothesis that resveratrol intake has beneficial effects on memory performance in comparison to placebo intake, using Bonferroni threshold (α = 0.05 divided by the number of tests per category).</s><s>Secondary hypotheses comprised detection of changes in glucose metabolism and HC RSFC and structure.</s><s>For all secondary analyses no adjustment for multiple testing was applied.</s></p><p><s>HC seed-based RSFC group analysis included gray mattervoxelwise GLM statistics, implemented in FSL, between changes in HC RSFC in the resveratrol group compared with those in the placebo group, using a cerebral gray matter mask (cerebellum excluded).</s><s>Gaussian random field theory was used to correct for multiple comparisons at the cluster level (FSL easythresh, clusterwise correction, z &gt; 2.3, p &lt; 0.05).</s></p><p><s>Initially all analyses were conducted unadjusted.</s><s>Additionally, analyses with 40 available datasets (memory performance and glucose control) were corrected for 4 covariates (age, sex, APOE e4 carrier status, and education) and analyses with 30 available data sets (MRI analyses) were corrected for 3 covariates (age, sex, and APOE e4 carrier status), to allow adjustment for important covariates but to avoid over-fitting <ref type="bibr" target="#b45">Stoltzfus (2011)</ref>.</s></p><p><s>To detect associations between changes in glucose parameters, HC structure and RSFC, and memory performance after the 26-week intervention, we ran bivariate correlations; Pearson or Spearman's rank correlation analysis, according to distribution of the data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline Characteristics</head><p><s>At baseline, both intervention groups were similar with regard to sex, age, years of education, cardiovascular and psychological risk factors, standard markers for lipid and inflammatory status, physical activity and MMSE scores (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The placebo group comprised a higher number of APOE e4 carriers (59%) and a higher concentration of high-sensitive CRP (2,1 pg/ml) compared to the resveratrol group (28% and 1,3 pg/ml).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Memory Performance</head><p><s>Mean scores of all AVLT subtests, i.e., learning ability, delayed recall, retention and recognition, were comparable between intervention groups at baseline (see Table <ref type="table" target="#tab_1">2</ref>).</s><s>Against our primary hypothesis no interaction effect of group × time was found for memory performance (ANOVA RM ; all ds ≤ 0.471; p ≥ 0.157, Bonferroni corrected).</s><s>Adjustment for age, sex, APOE e4-carrier status and education as well as a separate analysis for male and female patients did not change the results.</s><s>For details see Table <ref type="table" target="#tab_1">2</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Changes in Parameters of Glucose Control</head><p><s>At baseline, parameters of glucose control were similar in both intervention groups (see Table <ref type="table" target="#tab_2">3</ref>).</s></p><p><s>An interaction effect of group × time was found for HbA1c with a moderate effect size of d = 0.66 [ANOVA RM , F (1, 35) = 3.80, p = 0.059], similar after full adjustment for age, sex, APOE e4 carrier status and education [ANCOVA RM , F (1, 31) = 3.6, p = 0.066, d = 0.65].</s><s>Here, the long-term glucose marker HbA1c was significantly reduced in MCI patients after resveratrol intervention [−0.15%; paired t-test; t (17) = 3.3, p = 0.005, d = this was not the case in the placebo group (−0.02%) (Figure <ref type="figure" target="#fig_0">2</ref>).</s><s>For glucose and insulin no group × time interaction effects and no changes over time in both groups were observed.</s><s>For details see Table <ref type="table" target="#tab_2">3</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hippocampus Resting-State Functional Connectivity</head><p><s>The seed-based RSFC analysis revealed that resveratrol intervention significantly increased functional connectivity between the right HC seed and a cluster in the right angular cortex compared to placebo (Figure <ref type="figure" target="#fig_1">3</ref>, yellow-red, cluster of 523 voxels, hot voxel: x = 60, y = −56, z = 10, p &lt; 0.001).</s><s>This effect was primarily driven by the anterior part of the right HC (cluster of 557 voxels, hot voxel: x = 60, y = −58, z = 10, p &lt; 0.001).</s><s>Results did not change after adjustment for age, sex and APOE e4 carrier status (p &lt; 0.001) and after correction for multiple comparisons (FSL easythresh).</s><s>The decrease in HbA1c did not significantly correlate with the increase in RSFC in the resveratrol group (r = −0.131,</s><s>p = 0.665).</s><s>We did not find significant group differences for the opposite contrast (placebo intervention &gt; resveratrol intervention).</s><s>No significant group differences were observed in correlations between the left HC seed and other gray matter brain regions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gray Matter Volume, Hippocampus Volume, and Microstructure</head><p><s>At baseline, total gray matter volume, and volume and microstructure of the HC were similar between both groups (see Table <ref type="table" target="#tab_3">4</ref>).</s></p><p><s>At between-group level, total gray matter volume was similar after intervention period in both groups [ANCOVA RM, F (28) = 0.272, p = 0.606, d = 0.20].</s><s>A group × time interaction effect was found for the atrophy rate of the left HC with a moderate effect size of d = 0.68 [ANCOVA RM ; F (28) = 3.2, p = 0.084], particularly for the left anterior HC [ANCOVA RM ; F (28) = 3.8, p = 0.061, d = 0.74] after no adjustment, and was still present after full adjustment for age, sex, and APOE e4 carrier status [ANCOVA RM ; left HC, F (24) = 2.3, p = 0.144, d = 0.57; left anterior HC, F (24) = 3.2, p = 0.088, d = 0.68].</s><s>Patients of the placebo group showed a decrease of −4.2% in volume of the left, specifically left anterior (−4.5%)</s><s>HC, whereas the volume was preserved in the resveratrol group (+0.3%).</s><s>No group × time interaction effects were found for changes in volume of the left posterior HC and the right HC of both groups.</s><s>For details see Table <ref type="table" target="#tab_3">4 and Figure 4</ref>.</s></p><p><s>Turning to HC microstructure, no selective differences were noted between groups for changes in mean diffusivity of the HC over time (see Table <ref type="table" target="#tab_3">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>In this proof-of-concept study with MCI patients, we demonstrated that daily supplementation with 200 mg resveratrol over 26 weeks led to a moderate decrease in HbA1c (non-significant), a long-term marker of glucose control, in comparison to placebo.</s><s>Moreover, supplementation significantly increased RSFC between the right HC and the right angular cortex and preserved the volume of the left, particularly anterior, HC with a moderate effect size (non-significant).</s><s>Beneficial effects of resveratrol on memory performance and HC microstructure were not found.</s></p><p><s>The pathogenesis of "typical Alzheimer's disease" has been divided in sequential disease stages, characterized by changes in different biomarkers over time <ref type="bibr" target="#b21">(Jack et al., 2013)</ref>.</s><s>According to this model, an initial increase in Aß deposition is followed by Tau pathology, hypometabolism, brain atrophy particularly of the HC, and finally cognitive dysfunction.</s><s>Within this model, changes in the functional organization of the brain represent a promising diagnostic biomarker in early disease stages, preceding structural brain changes <ref type="bibr" target="#b38">(Pievani et al., 2011)</ref>.</s><s>Notably, changes in RSFC are known to reflect dynamic modulations of blood flow and brain activity, well before structural alterations <ref type="bibr" target="#b44">(Sheline et al., 2010;</ref><ref type="bibr" target="#b40">Prvulovic et al., 2011;</ref><ref type="bibr" target="#b4">Brickman et al., 2014)</ref>, and may therefore constitute a highly sensitive biomarker to detect subtle changes due to dietary modifications.</s><s>Moreover, it has been shown in previous studies that dietary changes can influence RSFC <ref type="bibr" target="#b16">(Grayson et al., 2014;</ref><ref type="bibr" target="#b54">Witte et al., 2014;</ref><ref type="bibr" target="#b50">Wiesmann et al., 2016)</ref>.</s><s>A randomized controlled crossover study by <ref type="bibr" target="#b22">Kennedy et al. (2010)</ref> demonstrated that a single dose of resveratrol was sufficient to increase cerebral blood flow, measured by near-infrared spectroscopy.</s><s>However, long-term interventional studies that investigate the beneficial potential of nutritional components by measuring brain RSFC are still limited.</s><s>In an own study with healthy older adults, resveratrol supplementation over 26 weeks compared to placebo significantly improved RSFC of the HC <ref type="bibr" target="#b54">(Witte et al., 2014)</ref>.</s><s>Here, we were partially able to confirm these findings, i.e., found a significant increase in RSFC between the right HC and the right angular cortex in MCI patients, supporting the positive influence of resveratrol on brain networks even in early disease-stages.</s><s>HC and angular gyrus are structurally and functionally connected <ref type="bibr" target="#b49">(Uddin et al., 2010)</ref>, and constitute core areas within the default mode network, known to be related to memory function <ref type="bibr" target="#b32">(McCormick et al., 2014)</ref> and to deteriorate in aging and neurodegenerative disease <ref type="bibr" target="#b11">(Dennis and Thompson, 2014)</ref>.</s></p><p><s>In addition, resveratrol supplementation showed a moderate effect (non-significant) on preservation of hippocampal volume, which was decreased over time in the placebo group.</s><s>This result is in line with a reduction of neurodegeneration and/or an increase in neurogenesis of the HC observed after resveratrol injection in rodent models, even in older age <ref type="bibr" target="#b24">(Kim et al., 2007;</ref><ref type="bibr" target="#b26">Kodali et al., 2015)</ref>.</s><s>In our previous resveratrol trial with healthy older adults, we could not demonstrate a beneficial effect of resveratrol on HC structure.</s><s>However, the specific cohort in that study, i.e., healthy older adults, might have prevented us from observing significant differences, due to lower atrophy rates over the course of 6 months in the healthy group <ref type="bibr" target="#b54">(Witte et al., 2014)</ref>.</s><s>MCI patients show a stronger atrophy rate within 6 months compared to healthy older adults <ref type="bibr" target="#b33">(McDonald et al., 2009)</ref>, which might increase the probability for statistical detection of sensitive dietary effects on changes in brain morphology.</s><s>Given that we only found a moderate and non-significant effect of resveratrol on HC structure, longer intervention times may be necessary to induce significant changes <ref type="bibr" target="#b13">(Douaud et al., 2013)</ref>.</s></p><p><s>So far, studies on the impact of resveratrol on cognitive performance showed mixed results.</s><s>First interventional studies have shown that resveratrol supplementation over 18 and 6 months, respectively, improved spatial memory performance in non-human primates <ref type="bibr" target="#b8">(Dal-Pan et al., 2011)</ref>, and increased the number of words retained over 30 min in healthy older adults <ref type="bibr" target="#b54">(Witte et al., 2014)</ref>.</s><s>In contrast, in a recently published randomized-controlled trial, resveratrol intervention over 28 days was not sufficient to induce clear improvements in cognitive function, showing merely improvements in working memory performance (i.e., accuracy in the 3-back task), but not in tasks related to attention and executive function <ref type="bibr" target="#b51">(Wightman et al., 2015)</ref>.</s><s>In the current study, we did not detect resveratrol-related beneficial effects on learning and memory performance in MCI patients, possibly due to the small sample size and still relatively short intervention time [6 months as compared to 24 months in a nutritional study with B-vitamin supplementation that demonstrated improvement in episodic memory performance <ref type="bibr" target="#b9">(de Jager et al., 2012)</ref>].</s><s>Thus, our study design may have only allowed for changes in RSFC and moderate effects on structure but not yet for "downstream" cognitive effects.</s><s>Neuroprotective mechanisms that might explain the link between resveratrol and improved brain structure, and eventually function, include reductions in mitochondrial dysfunction, oxidative damage, glucose toxicity, and chronic inflammation, by improving glucose metabolism and vascular functions, see also <ref type="bibr" target="#b20">Huhn et al. (2015)</ref> for detailed review.</s><s>Moreover, resveratrol is described as a potential activator of the sirtuin pathway that is regulated by NAD+/NADH, linking energy metabolism to gene expression <ref type="bibr" target="#b47">(Timmers et al., 2011;</ref><ref type="bibr" target="#b31">Li, 2013)</ref>.</s><s>Our previous study in healthy older adults demonstrated a significant decrease in the long-term glucose marker HbA1c after resveratrol intervention compared to placebo <ref type="bibr" target="#b54">(Witte et al., 2014)</ref>.</s><s>In line with these findings, we also found a moderate, but non-significant, reduction in HbA1c after 26 weeks resveratrol treatment in MCI patients in comparison to an unchanged value after placebo intake.</s><s>These findings point toward resveratrol-induced modulations of glucose control as one possible mechanism underlying beneficial effects on RSFC <ref type="bibr" target="#b46">(Stranahan and Mattson, 2008)</ref>.</s><s>Some limitations should be considered when interpreting our findings.</s><s>First, the small number of patients in both groups might have prevented us from observing statistically significant changes in memory function and secondary outcome parameters, i.e., HbA1c, and HC volume and microstructure.</s><s>Second, an intervention time of 26 weeks might be too short to reach significant beneficial effects.</s><s>Third, intervention and placebo group differed in the number of APOE e4 carriers, which might have biased the results; however, adjustment for APOE e4 status did not attenuate the moderate (non-significant) effects.</s><s>Fourth, self-reported information by the patients and count of remaining capsules were the only compliance measure, but group-specific decrease in HbA1c supports patients' adherence.</s><s>Fifth, resveratrol was given in a formula with quercetin to increase its bioavailability <ref type="bibr" target="#b12">(De Santi et al., 2000)</ref>, whereby an impact of quercetin itself on brain function cannot be excluded.</s><s>However, in a randomized-controlled trial even higher doses of quercetin (500 mg/d or 1,000 mg/d) did not show ergogenic effects on neurocognitive functioning in humans <ref type="bibr" target="#b5">(Broman-Fulks et al., 2012)</ref>.</s></p><p><s>In sum, we were able to partially translate previously reported beneficial effects of resveratrol from healthy older adults to at-risk patients for Alzheimer's disease, showing significantly increased HC RSFC, and moderate improvements in glucose metabolism and HC structure (non-significant).</s><s>We believe that these findings support resveratrol as a potential non-pharmacological agent to modify the disease process in MCI patients.</s><s>However, larger and long-term interventional trials in patients are now needed to confirm or refute beneficial effects observed on sensitive surrogate markers for hippocampal function, and to determine if these findings also extend to cognitive function.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR CONTRIBUTIONS</head><p><s>Substantial contributions to the conception or design of the work: AW and AF.</s><s>Data acquisition: TK, AS, VT, JP, JS, AH, and JB.</s><s>Data analyses: TK, AW, and UG.</s><s>Data interpretation and discussion: TK, AW, AS, VT, JP, JS, AH, and AF.</s><s>Manuscript drafting: TK, AW, and AF.</s><s>Revising Manuscript critically for important intellectual content: TK, AW, AS, VT, JP, JS, AH, JB, UG, and AF.</s><s>Final approval of the version to be published: TK and AF.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 2 |</head><label>2</label><figDesc><div><p><s>FIGURE 2 | A moderate, but non-significant decrease in the long-term glucose marker HbA1c after 26 weeks resveratrol intervention (n = 18) compared to placebo intervention (n = 19) (ANCOVA RM p = 0.059, d = 0.66).</s><s>The decrease reached statistical significance when analyzing the resveratrol group separately (paired t-test p = 0.005).</s><s>HbA1c, glycated hemoglobin A1c.</s></p></div></figDesc><graphic coords="7,52.50,70.08,229.68,246.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 3 |</head><label>3</label><figDesc><div><p><s>FIGURE 3 | Significant increase in resting-state functional connectivity between the right HC and the right angular cortex after 26 weeks resveratrol intervention (n = 14) compared to placebo intervention (n = 16).</s><s>Color bar indicate t-values of significant voxels (resveratrol intervention &gt; placebo intervention;cluster-based thresholding, p &lt; 0.05).</s><s>Individual masks of the left and right HC were used as seeds in the analysis.</s><s>No group differences were observed for the opposite contrast (placebo intervention &gt; resveratrol intervention), and when using the left HC as seed.</s><s>For better visualization we superimposed the t-map on the MNI-template.</s><s>Images are displayed in neurological convention, coordinates in mm according to MNI space.</s><s>A, anterior; H, hippocampus; L, left; R, right; P, posterior.</s></p></div></figDesc><graphic coords="8,113.63,70.00,368.40,157.68" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 4 |</head><label>4</label><figDesc><div><p><s>FIGURE 4 | A moderate, but non-significant, preservation of gray matter atrophy of the left, particularly anterior, hippocampus after 26 weeks resveratrol supplementation (n = 14) compared to placebo (n = 16) (ANCOVA RM ; left Hippocampus, p = 0.084, d = 0.68; left anterior Hippocampus, p = 0.061, d = 0.74).</s><s>Error bars indicate standard error.</s></p></div></figDesc><graphic coords="9,112.14,69.55,371.40,198.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="3,112.14,69.47,371.28,259.20" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1 |</head><label>1</label><figDesc><div><p><s>Baseline characteristics of MCI patients dependent on group.</s></p></div></figDesc><table><row><cell>Characteristic</cell><cell>Resveratrol</cell><cell>Placebo</cell></row><row><cell>parameters</cell><cell></cell><cell></cell></row><row><cell>n (Women) [n]</cell><cell>18 (10)</cell><cell>22 (11)</cell></row><row><cell>Age [years]</cell><cell>65 ± 9 (50-80)</cell><cell>69 ± 7 (51-79)</cell></row><row><cell>Education [years]</cell><cell>14 ± 4 (8-20)</cell><cell>16 ± 3 (11-19)</cell></row><row><cell>Body mass index</cell><cell>26 ± 3 (20-31)</cell><cell>26 ± 3 (23-32)</cell></row><row><cell>(BMI) [kg/m 2 ]</cell><cell></cell><cell></cell></row><row><cell>Right-handedness</cell><cell>90 ± 11 (70-100)</cell><cell>81 ± 37 (−50-100)</cell></row><row><cell>[%] a</cell><cell></cell><cell></cell></row><row><cell>Systolic blood</cell><cell>140 ± 20 (117-177)</cell><cell>145 ± 14 (115-168)</cell></row><row><cell>pressure [mm Hg] a</cell><cell></cell><cell></cell></row><row><cell>LDL-to-HDL ratio</cell><cell>2.5 ± 0.8 (1.4-4.2)</cell><cell>2.2 ± 0.7 (0.9-3.7)</cell></row><row><cell>hsCRP [pg/ml] c</cell><cell>1.3 ± 2.2 (0.3-9.3)</cell><cell>2.1 ± 1.9 (0.3-7.9)</cell></row><row><cell>Smoking [pack</cell><cell>11 ± 14 (0-38)</cell><cell>4 ± 8 (0-30)</cell></row><row><cell>years] a</cell><cell></cell><cell></cell></row><row><cell>Physical activity</cell><cell cols="2">3,734 ± 3,844 (321-13,034) 3,199 ± 2,486 (435-9,295)</cell></row><row><cell>[kcal/week] a</cell><cell></cell><cell></cell></row><row><cell>Beck's Depression</cell><cell>9 ± 6 (0-20)</cell><cell>9 ± 6 (0-20)</cell></row><row><cell>Index (BDI) [score] b</cell><cell></cell><cell></cell></row><row><cell>State-Trait Anxiety</cell><cell>34 ± 6 (23-45)</cell><cell>39 ± 9 (22-56)</cell></row><row><cell>Inventory-X1 [score]</cell><cell></cell><cell></cell></row><row><cell>Mini mental state</cell><cell>28 ± 2 (24-30)</cell><cell>29 ± 1 (26-30)</cell></row><row><cell>examination (MMSE)</cell><cell></cell><cell></cell></row><row><cell>[score]</cell><cell></cell><cell></cell></row><row><cell>Apolipoprotein_</cell><cell>13; 5</cell><cell>9; 13</cell></row><row><cell>rs429358/rs7412</cell><cell></cell><cell></cell></row><row><cell>[n e4−; e4+]</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2 |</head><label>2</label><figDesc><div><p><s>Intervention related changes in declarative memory performance of MCI patients dependent on group and time.Number of words in different subtests of the auditory verbal learning test expressed as mean ± SD (raw data).</s><s>BL, baseline; FU, follow-up.</s><s>ANCOVA RM , adjusted for age, sex, APOE e4 status and education.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Resveratrol (n = 18)</cell><cell></cell><cell></cell><cell>Placebo (n = 22)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>BL</cell><cell>FU</cell><cell>p-value</cell><cell>BL</cell><cell>FU</cell><cell>p-value</cell><cell>Unadjusted p-value</cell><cell>Adjusted p-value</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(group × time) c</cell><cell>(group × time) d</cell></row><row><cell>Learning ability</cell><cell>44.9 ± 9.5</cell><cell>43.0 ± 10.7</cell><cell>0.314 a</cell><cell>44.2 ± 8.1</cell><cell>41.9 ± 12.8</cell><cell>0.495 b</cell><cell>0.878</cell><cell>0.840</cell></row><row><cell>Delayed recall</cell><cell>7.6 ± 3.9</cell><cell>6.7 ± 3.9</cell><cell>0.173 a</cell><cell>7.2 ± 2.7</cell><cell>7.6 ± 3.7</cell><cell>0.536 a</cell><cell>0.157</cell><cell>0.126</cell></row><row><cell>Retention</cell><cell>−3.4 ± 2.1</cell><cell>−3.8 ± 2.6</cell><cell>0.444 a</cell><cell>−3.8 ± 2.2</cell><cell>−3.3 ± 2.2</cell><cell>0.505 a</cell><cell>0.325</cell><cell>0.249</cell></row><row><cell>Recognition</cell><cell>9.8 ± 5.9</cell><cell>8.4 ± 6.2</cell><cell>0.122 b</cell><cell>9.3 ± 4.2</cell><cell>7.7 ± 6.0</cell><cell>0.152 b</cell><cell>0.882</cell><cell>0.806</cell></row></table><note><p><s>a Paired t-test.</s><s>b Wilcoxon signed-rank test.</s><s>c ANOVA RM , unadjusted.</s><s>d</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE 3 |</head><label>3</label><figDesc><div><p><s>Intervention related changes in fasting serum parameters of glucose metabolism of MCI patients dependent on group and time.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Resveratrol = 18)</cell><cell></cell><cell cols="2">Placebo (n = 22)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>BL</cell><cell>FU</cell><cell>p-value</cell><cell>BL</cell><cell>FU</cell><cell>p-value</cell><cell>Unadjusted p-value</cell><cell>Adjusted p-value</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(group × time) c</cell><cell>(group × time) d</cell></row><row><cell>HbA1c [%] e</cell><cell>5.86 ± 0.36</cell><cell>5.71 ± 0.33</cell><cell>0.005 a</cell><cell>5.73 ± 0.29</cell><cell>5.71 ± 0.28</cell><cell>0.769 b</cell><cell>0.059</cell><cell>0.066</cell></row><row><cell>Glucose [mg/dl] f</cell><cell>97.6 ± 13.1</cell><cell>101.8 ± 25.0</cell><cell>0.392 a</cell><cell>96.7 ± 15.2</cell><cell>97.2 ± 15.1</cell><cell>0.807 b</cell><cell>0.468</cell><cell>0.297</cell></row><row><cell>Insulin [mU]</cell><cell>8.7 ± 3.7</cell><cell>10.4 ± 12.6</cell><cell>0.349 b</cell><cell>9.2 ± 4.1</cell><cell>9.0 ± 5.8</cell><cell>0.163 b</cell><cell>0.521</cell><cell>0.402</cell></row></table><note><p><s>Data expressed as mean ± SD.Significant results are highlighted in bold (p &lt; 0.05).BL, baseline; FU, follow-up; HbA1c, glycated hemoglobin A1c.a Paired t-test.</s><s>b Wilcoxon signed-rank test.</s><s>c ANOVA RM , unadjusted.</s><s>d ANCOVA RM , adjusted for age, sex, APOE e4 status and education.</s><s>e Three subject excluded due to missing values (placebo group).</s><s>f One subject excluded due to missing values (placebo group).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE 4 |</head><label>4</label><figDesc><div><p><s>Intervention related changes in gray matter volume, and volume and microstructure of the hippocampus of MCI patients dependent on group and time.</s><s>ANCOVA RM , adjusted for age, sex, and APOE e4 status.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Resveratrol (n = 14)</cell><cell></cell><cell cols="2">Placebo (n = 16)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>BL</cell><cell>FU</cell><cell>p-value a</cell><cell>BL</cell><cell>FU</cell><cell>p-value a</cell><cell>Unadjusted p-value</cell><cell>Adjusted p-value</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(group × time) b</cell><cell>(group × time) c</cell></row><row><cell>Total GM volume [cm 3 ]</cell><cell cols="2">542.8 ± 68.6 540.6 ± 65.1</cell><cell>0.454</cell><cell cols="2">552.1 ± 50.5 547.0 ± 55.6</cell><cell>0.301</cell><cell>0.606</cell><cell>0.744</cell></row><row><cell>HC, LEFT</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Volume [cm 3 ]</cell><cell>3.52 ± 0.6</cell><cell>3.53 ± 0.6</cell><cell>0.774</cell><cell>3.78 ± 0.6</cell><cell>3.62 ± 0.5</cell><cell>0.073</cell><cell>0.084</cell><cell>0.113</cell></row><row><cell>MD [m 2 /s]</cell><cell>1.10 ± 0.19</cell><cell>1.12 ± 0.14</cell><cell>0.629</cell><cell>1.14 ± 0.09</cell><cell>1.14 ± 0.11</cell><cell>0.736</cell><cell>0.544</cell><cell>0.131</cell></row><row><cell>HC, LEFT ANT</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Volume [cm 3 ]</cell><cell>2.04 ± 0.4</cell><cell>2.06 ± 0.3</cell><cell>0.583</cell><cell>2.24 ± 0.3</cell><cell>2.14 ± 0.3</cell><cell>0.063</cell><cell>0.061</cell><cell>0.061</cell></row><row><cell>MD [m 2 /s]</cell><cell>1.16 ± 0.16</cell><cell>1.15 ± 0.17</cell><cell>0.850</cell><cell>1.17 ± 0.10</cell><cell>1.17 ± 0.13</cell><cell>0.686</cell><cell>0.899</cell><cell>0.380</cell></row><row><cell>HC, LEFT POST</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Volume [cm 3 ]</cell><cell>1.47 ± 0.2</cell><cell>1.47 ± 0.3</cell><cell>0.863</cell><cell>1.55 ± 0.2</cell><cell>1.48 ± 0.2</cell><cell>0.133</cell><cell>0.222</cell><cell>0.340</cell></row><row><cell>MD [m 2 /s]</cell><cell>1.09 ± 0.20</cell><cell>1.07 ± 0.10</cell><cell>0.503</cell><cell>1.09 ± 0.08</cell><cell>1.09 ± 0.1</cell><cell>0.803</cell><cell>0.620</cell><cell>0.468</cell></row><row><cell>HC, RIGHT</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Volume [cm 3 ]</cell><cell>3.71 ± 0.5</cell><cell>3.75 ± 0.5</cell><cell>0.463</cell><cell>3.82 ± 0.6</cell><cell>3.72 ± 0.6</cell><cell>0.257</cell><cell>0.183</cell><cell>0.107</cell></row><row><cell>MD [m 2 /s]</cell><cell>1.09 ± 0.12</cell><cell>1.15 ± 0.09</cell><cell>0.029</cell><cell>1.16 ± 0.09</cell><cell>1.18 ± 0.11</cell><cell>0.171</cell><cell>0.275</cell><cell>0.063</cell></row><row><cell>HC, RIGHT ANT</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Volume [cm 3 ]</cell><cell>2.17 ± 0.3</cell><cell>2.18 ± 0.3</cell><cell>0.848</cell><cell>2.26 ± 0.4</cell><cell>2.20 ± 0.3</cell><cell>0.253</cell><cell>0.316</cell><cell>0.168</cell></row><row><cell>MD [m 2 /s]</cell><cell>1.16 ± 0.10</cell><cell>1.20 ± 0.11</cell><cell>0.007</cell><cell>1.21 ± 0.12</cell><cell>1.23 ± 12.8</cell><cell>0.266</cell><cell>0.374</cell><cell>0.429</cell></row><row><cell>HC, RIGHT POST</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Volume [cm 3 ]</cell><cell>1.53 ± 0.2</cell><cell>1.57 ± 0.2</cell><cell>0.218</cell><cell>1.56 ± 0.3</cell><cell>1.52 ± 0.2</cell><cell>0.231</cell><cell>0.093</cell><cell>0.071</cell></row><row><cell>MD [m 2 /s]</cell><cell>1.04 ± 0.08</cell><cell>1.06 ± 0.09</cell><cell>0.073</cell><cell>1.09 ± 0.07</cell><cell>1.12 ± 0.1</cell><cell>0.252</cell><cell>1.000</cell><cell>0.453</cell></row><row><cell cols="9">Number of words in different subtests of the auditory verbal learning test expressed as mean ± SD (raw data). Ant, anterior; BL, baseline; FU, follow-up; HC, hippocampus; MD, mean</cell></row><row><cell>diffusivity; post, posterior.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a Paired t-test.</s><s>b ANOVA RM , unadjusted.</s><s>c Significant results are highlighted in bold (p &lt; 0.05).</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Frontiers in Neuroscience | www.frontiersin.org</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">March 2017 | Volume 11 | Article 105</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>This work was supported by grants from the Deutsche Forschungsgemeinschaft (Fl 379-10/1; Fl 379-11/1, and DFG-Exc 257) and the Bundesministerium für Bildung und Forschung (FKZ 0315673A, 01EO0801, 01GQ1424A, 01GQ1420B).</s><s>ClinicalTrials.gov</s><s>Identifier: NCT01219244.</s><s>We thank Dr. Angela Winkler, Mareike Wegmann, Dr. Anders Graunke, and Maxime Bee for help with data acquisition.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest Statement:</head><p><s>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Functional-anatomic fractionation of the brain&apos;s default network</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Andrews-Hanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Reidler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sepulcre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Poulin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Buckner</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2010.02.005</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="550" to="562" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Bhatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Nanjan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nutres.2012.06.003</idno>
	</analytic>
	<monogr>
		<title level="j">Nutr. Res</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="537" to="541" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Toward discovery science of human brain function</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Biswal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mennes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">N</forename><surname>Zuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gohel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0911855107</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="4734" to="4739" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients</title>
		<author>
			<persName><forename type="first">P</forename><surname>Brasnyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Molnar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mohas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laczy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cseh</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0007114511000316</idno>
	</analytic>
	<monogr>
		<title level="j">Br. J. Nutr</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="383" to="389" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Brickman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Provenzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Yeung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schroeter</surname></persName>
		</author>
		<idno type="DOI">10.1038/nn.3850</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1798" to="1803" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The effects of quercetin supplementation on cognitive functioning in a community sample: a randomized, placebo-controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Broman-Fulks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Canu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Trout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Nieman</surname></persName>
		</author>
		<idno type="DOI">10.1177/2045125312445894</idno>
	</analytic>
	<monogr>
		<title level="j">Ther. Adv. Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="131" to="138" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&apos;s disease in late onset families</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Corder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Schmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gaskell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Small</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.8346443</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">261</biblScope>
			<biblScope unit="page" from="921" to="923" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Pilot study of resveratrol in older adults with impaired glucose tolerance</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Crandall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Oram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Trandafirescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kishore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hawkins</surname></persName>
		</author>
		<idno type="DOI">10.1093/gerona/glr235</idno>
	</analytic>
	<monogr>
		<title level="j">J. Gerontol. Ser. A Biol. Sci. Med. Sci</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1307" to="1312" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cognitive performances are selectively enhanced during chronic caloric restriction or resveratrol supplementation in a primate</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dal-Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pifferi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marchal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Picq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aujard</forename></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0016581</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e16581</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>De Jager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oulhaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jacoby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Refsum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1002/gps.2758</idno>
	</analytic>
	<monogr>
		<title level="j">Int. J. Geriatr. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="592" to="600" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Structural and diffusion MRI measures of the hippocampus and memory performance</title>
		<author>
			<persName><forename type="first">T</forename><surname>Den Heijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">V</forename><surname>Der Lijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Vernooij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Koudstaal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Der Lugt</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroimage.2012.08.067</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1782" to="1789" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Functional brain connectivity using fMRI in aging and Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11065-014-9249-6</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropsychol. Rev</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="49" to="62" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids</title>
		<author>
			<persName><forename type="first">De</forename><surname>Santi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pietrabissa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spisni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mosca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pacifici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename></persName>
		</author>
		<idno type="DOI">10.1080/004982500433282</idno>
	</analytic>
	<monogr>
		<title level="j">Xenobiotica</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="857" to="866" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Preventing Alzheimer&apos;s disease-related gray matter atrophy by B-vitamin treatment</title>
		<author>
			<persName><forename type="first">G</forename><surname>Douaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Refsum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>De Jager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jacoby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Nichols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1301816110</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="9523" to="9528" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The BDNF val66met polymorphism affects activitydependent secretion of BDNF and human memory and hippocampal function</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Egan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Callicott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Kolachana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bertolino</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0092-8674(03)00035-7</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="257" to="269" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Freiburg Questionnaire of physical activity-development, evaluation and application</title>
		<author>
			<persName><forename type="first">I</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grathwohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Keul</surname></persName>
		</author>
		<idno type="DOI">10.1007/BF01667127</idno>
	</analytic>
	<monogr>
		<title level="j">Soz. Praventivmed</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="55" to="64" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Dietary omega-3 fatty acids modulate large-scale systems organization in the rhesus macaque brain</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Grayson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Kroenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Neuringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Fair</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.3038-13.2014</idno>
		<idno>doi: 10.1523/ JNEUROSCI.3038-13.2014</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="2065" to="2074" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">New perspectives on Alzheimer&apos;s disease and nutrition</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Gustafson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Clare</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scarmeas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Sijben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
		<idno type="DOI">10.3233/JAD-150084</idno>
	</analytic>
	<monogr>
		<title level="j">J. Alzheimer&apos;s Dis</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1111" to="1127" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">N</forename><surname>Harada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kurihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nakagata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Okajima</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus</title>
		<idno type="DOI">10.1016/j.jnutbio.2010.09.016</idno>
	</analytic>
	<monogr>
		<title level="j">J. Nutr. Biochem</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1150" to="1159" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Components of a Mediterranean diet and their impact on cognitive functions in aging</title>
		<author>
			<persName><forename type="first">S</forename><surname>Huhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kharabian Masouleh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stumvoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Villringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Witte</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnagi.2015.00132</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Aging Neurosci</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">132</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Tracking pathophysiological processes in Alzheimer&apos;s disease: an updated hypothetical model of dynamic biomarkers</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Jack</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Knopman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Jagust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Aisen</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1474-4422(12)70291-0</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="207" to="216" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Wightman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Reay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Okello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wilde</surname></persName>
		</author>
		<idno type="DOI">10.3945/ajcn.2009.28641</idno>
	</analytic>
	<monogr>
		<title level="j">Am. J. Clin. Nutr</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="1590" to="1597" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Higher glucose levels associated with lower memory and reduced hippocampal microstructure</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kerti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grittner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rujescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Flöel</surname></persName>
		</author>
		<idno type="DOI">10.1212/01.wnl.0000435561.00234.ee</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1746" to="1752" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer&apos;s disease and amyotrophic lateral sclerosis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Dobbin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sananbenesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Rodgers</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.emboj.7601758</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="3169" to="3179" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment</title>
		<author>
			<persName><forename type="first">T</forename><surname>Köbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schnelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lesemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fabian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Tesky</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroimage.2015.09.050</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="226" to="238" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kodali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">K</forename><surname>Parihar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hattiangady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Shuai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Shetty</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep08075</idno>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">8075</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Untersuchung mit einer deutschen Version der &quot;Positive and Negative Affective Schedule</title>
		<author>
			<persName><forename type="first">H</forename><surname>Krohne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Egloff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kohlmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tausch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PANAS). Diagnostica</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="139" to="156" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples</title>
		<author>
			<persName><forename type="first">C</forename><surname>Kuhner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Burger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hautzinger</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00115-006-2098-7</idno>
	</analytic>
	<monogr>
		<title level="j">Der. Nervenarzt</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="651" to="656" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Das State-Trait-Angstinventar</title>
		<author>
			<persName><forename type="first">L</forename><surname>Laux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Glanzmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schaffner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Spielberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Theoretische Grundlagen und Handanweisung. Weinheim: Beltz Test GmbH</title>
		<imprint>
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">Neuropsychological Assessment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lezak</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>Oxford University Press</publisher>
			<pubPlace>New York, NY; Oxford</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">SIRT1 and energy metabolism</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1093/abbs/gms108</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Biochim. Biophys. Sin. (Shanghai)</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="51" to="60" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Linking DMN connectivity to episodic memory capacity: what can we learn from patients with medial temporal lobe damage?</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mccormick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Protzner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Barnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Valiante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcandrews</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nicl.2014.05.008</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroimage Clin</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="188" to="196" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Regional rates of neocortical atrophy from normal aging to early Alzheimer disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Mcevoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gharapetian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fennema-Notestine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Hagler</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Holland</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.0b013e3181b16431</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="457" to="465" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The consortium to establish a registry for Alzheimer&apos;s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Mohs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Belle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fillenbaum</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.39.9.1159</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="1159" to="1165" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study</title>
		<author>
			<persName><forename type="first">L</forename><surname>O'dwyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lamberton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scheibe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0048895</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e48895</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The assessment and analysis of handedness: the Edinburgh inventory</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Oldfield</surname></persName>
		</author>
		<idno type="DOI">10.1016/0028-3932(71)90067-4</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropsychologia</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="97" to="113" />
			<date type="published" when="1971">1971</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Mild cognitive impairment: clinical characterization and outcome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Waring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ivnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Tangalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kokmen</surname></persName>
		</author>
		<idno type="DOI">10.1001/archneur.56.3.303</idno>
	</analytic>
	<monogr>
		<title level="j">Arch. Neurol</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="303" to="308" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Functional network disruption in the degenerative dementias</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pievani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>De Haan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Seeley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1474-4422(11)70158-2</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="829" to="843" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Dietary resveratrol prevents Alzheimer&apos;s markers and increases life span in SAMP8</title>
		<author>
			<persName><forename type="first">D</forename><surname>Porquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Casadesus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bayod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vicente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Canudas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vilaplana</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11357-012-9489-4</idno>
	</analytic>
	<monogr>
		<title level="j">Age (Dordr)</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1851" to="1865" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Prvulovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Bokde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Faltraco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hampel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pneurobio.2011.05.008</idno>
	</analytic>
	<monogr>
		<title level="j">Prog. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="557" to="569" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">V1 activation in congenitally blind humans is associated with episodic retrieval</title>
		<author>
			<persName><forename type="first">N</forename><surname>Raz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Amedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zohary</surname></persName>
		</author>
		<idno type="DOI">10.1093/cercor/bhi026</idno>
	</analytic>
	<monogr>
		<title level="j">Cereb. Cortex</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1459" to="1468" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Ries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Carlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Rowley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Gleason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Asthana</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1532-5415.2008.01684.x</idno>
	</analytic>
	<monogr>
		<title level="j">J. Am. Geriatr. Soc</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="920" to="934" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Altered resting state networks in mild cognitive impairment and mild Alzheimer&apos;s disease: an fMRI study. Hum</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rombouts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Barkhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Goekoop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Stam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scheltens</surname></persName>
		</author>
		<idno type="DOI">10.1002/hbm.20160</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Mapp</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="231" to="239" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">I</forename><surname>Sheline</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Z</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>D'angelo</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.3987-10.2010</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="17035" to="17040" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Logistic regression: a brief primer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stoltzfus</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1553-2712.2011.01185.x</idno>
	</analytic>
	<monogr>
		<title level="j">Acad. Emerg. Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1099" to="1104" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Impact of energy intake and expenditure on neuronal plasticity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Stranahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Mattson</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12017-008-8043-0</idno>
		<idno>doi: 10.1007/ s12017-008-8043-0</idno>
	</analytic>
	<monogr>
		<title level="j">Neuromol. Med</title>
		<imprint>
			<biblScope unit="page" from="209" to="218" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans</title>
		<author>
			<persName><forename type="first">S</forename><surname>Timmers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Konings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bilet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Houtkooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Van De Weijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Goossens</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cmet.2011.10.002</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="612" to="622" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">A randomized, double-blind, placebocontrolled trial of resveratrol for Alzheimer disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Craft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Van Dyck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mintzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Reynolds</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.0000000000002035</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="1383" to="1391" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Dissociable connectivity within human angular gyrus and intraparietal sulcus: evidence from functional and structural connectivity</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Q</forename><surname>Uddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Supekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rykhlevskaia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Greicius</surname></persName>
		</author>
		<idno type="DOI">10.1093/cercor/bhq011</idno>
	</analytic>
	<monogr>
		<title level="j">Cereb. Cortex</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2636" to="2646" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">A dietary treatment improves cerebral blood flow and brain connectivity in aging apoE4 mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wiesmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Zerbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lutjohann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Broersen</surname></persName>
		</author>
		<idno type="DOI">10.1155/2016/6846721</idno>
	</analytic>
	<monogr>
		<title level="j">Neural Plast</title>
		<imprint>
			<biblScope unit="page">6846721</biblScope>
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Wightman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Haskell-Ramsay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Reay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0007114515003037</idno>
	</analytic>
	<monogr>
		<title level="j">Br. J. Nutr</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="1427" to="1437" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Calorie restriction reduces the influence of glucoregulatory dysfunction on regional brain volume in aged rhesus monkeys</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Willette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Bendlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Colman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Kastman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Field</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Alexander</surname></persName>
		</author>
		<idno type="DOI">10.2337/db11-1187</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1036" to="1042" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Effects of COMT polymorphisms on brain function and behavior in health and disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Floel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainresbull.2011.11.012</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Res. Bull</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="418" to="428" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kerti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Margulies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Floel</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.0385-14.2014</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="7862" to="7870" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">An emerging molecular and cellular framework for memory processing by the hippocampus</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Wittenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Tsien</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0166-2236(02)02231-2</idno>
	</analytic>
	<monogr>
		<title level="j">Trends Neurosci</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="501" to="505" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Chronic resveratrol consumption improves brachial flowmediated dilatation in healthy obese adults</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Coates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Buckley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kunz</surname></persName>
		</author>
		<idno type="DOI">10.1097/HJH.0b013e328362b9d6</idno>
	</analytic>
	<monogr>
		<title level="j">J. Hypertens</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1819" to="1827" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">N</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">D</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2013.05.025</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">435</biblScope>
			<biblScope unit="page" from="597" to="602" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
